StockWatch
·
Auto Components & Equipments
Board Meeting10 Aug 2026, 06:30 pm

Sharda Motor Q1FY27: Revenue +34% YoY, PAT -13% on margin compression (adj. +5%)

AI Summary

Sharda Motor's consolidated revenue from operations rose 33.7% YoY (and 4.0% QoQ) to ₹1,011.07 Cr in Q1 FY27, but consolidated PAT fell 13.4% YoY (-3.2% QoQ) to ₹86.53 Cr. The reported YoY decline is exaggerated by base effects: Q1 FY26 carried a ₹22.41 Cr exceptional gain from sale of PPE classified as held-for-sale, absent this quarter. Tax-effecting that one-off, adjusted YoY PAT growth is roughly +4.6% — a steady underlying print rather than the double-digit decline the headline number suggests. We found no analyst/consensus estimates for this quarter, so vsStreet is unknown. Margins compressed on both counts: net profit margin (PAT/total income) fell to ~8.3% from ~12.8% a year ago and ~9.0% last quarter, while operating margin (profit before exceptional items and tax/total income) fell to ~11.0% from ~16.0% YoY and ~11.8% QoQ. This runs counter to management's May 2026 concall framing that lightweighting margins were "decent and expected to improve" and that export margins would broadly track domestic margins — on this quarter's numbers, margin expansion has not yet shown up even as the topline growth management guided to (steady demand from new lightweighting/suspension orders and FY27 SOPs) is clearly visible in the 33.7% YoY revenue jump. No standalone/consolidated management press release was available in the context to cross-check company framing directly. Corporate developments this quarter were largely governance items rather than operational: the Board re-appointed Gurdeep Singh & Associates as cost auditors for FY27 and appointed Mr. Ajay Relan (currently Managing Director) as Whole-time Director for five years from September 1, 2026 — a succession-adjacent move given he is father of CEO Aashim Relan — alongside the routine trading-window closure ahead of results. None of these directly move the P&L this quarter. Standalone and consolidated results are closely aligned (PAT ₹85.78 Cr vs ₹86.53 Cr, EPS ₹14.94 vs ₹15.07), so the basis choice doesn't change the read. Going into Q2, the print sets up a test of whether the margin compression is transient (base-effect and mix related) or the start of a trend, against management's FY27 capex plan of ₹90-110 Cr for R&D and new facility readiness.

Key Highlights

  • Consolidated revenue from operations ₹1,011.07 Cr, up 33.7% YoY and 4.0% QoQ.
  • Consolidated PAT ₹86.53 Cr, down 13.4% YoY and 3.2% QoQ; adjusted for a ₹22.41 Cr one-off gain in the year-ago quarter, YoY PAT growth is ~+4.6%.
  • Net profit margin compressed to ~8.3% from ~12.8% a year ago and ~9.0% last quarter; operating margin ~11.0% vs ~16.0% YoY.
  • No exceptional items in Q1 FY27, versus a ₹22.41 Cr exceptional gain (profit on sale of PPE held for sale) in Q1 FY26.
  • Standalone PAT ₹85.78 Cr (EPS ₹14.94); consolidated PAT ₹86.53 Cr (EPS ₹15.07) — basis divergence under 1%.
  • Board appointed Mr. Ajay Relan as Whole-time Director from September 1, 2026 for five years, and re-appointed Gurdeep Singh & Associates as cost auditors for FY27.